TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314507. A total of 23 filers reported holding TITAN PHARMACEUTICALS INC DE in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $7,000 | – | 23,523 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Winning Points Advisors, LLC | 23,370 | $30,000 | 0.01% |
A.R.T. Advisors, LLC | 69,645 | $89,000 | 0.01% |
Virtu Financial LLC | 39,318 | $50,000 | 0.00% |
Blume Capital Management, Inc. | 425 | $1,000 | 0.00% |
VANGUARD GROUP INC | 582,180 | $746,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 35 | $0 | 0.00% |
UBS Group AG | 1,975 | $2,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 1 | $1,000 | 0.00% |
Advisor Group, Inc. | 350 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 6,125 | $8,000 | 0.00% |